Holen Sie sich die Stockscreener-App
2.57
2.28%
-0.06
Schlusskurs vom Vortag:
$2.63
Offen:
$2.635
24-Stunden-Volumen:
8.90M
Relative Volume:
0.84
Marktkapitalisierung:
$1.55B
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-8.0313
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
+0.39%
1M Leistung:
-13.18%
6M Leistung:
-43.39%
1J Leistung:
+33.16%
1-Tages-Spanne:
$2.555
$2.66
1-Wochen-Bereich:
$2.49
$2.70
52-Wochen-Spanne:
$1.64
$5.34
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Vergleichen Sie GERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
2.57 | 1.55B | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
GERNGeron Corp Latest Stock News & Market Updates - StockTitan
Commercial-Stage Biotech Geron Lines Up Triple Conference ShowcaseKey Dates Inside - StockTitan
Geron Co. (NASDAQ:GERN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Geron (GERN) to Release Quarterly Earnings on Wednesday - MarketBeat
What is B. Riley's Estimate for Geron FY2027 Earnings? - MarketBeat
B. Riley Has Lowered Expectations for Geron (NASDAQ:GERN) Stock Price - MarketBeat
Inside Geron's Latest Executive Compensation Package: Key Details on $2.63 Stock Options - StockTitan
4 Analysts Assess Geron: What You Need To Know - Benzinga
B.Riley cuts Geron stock price target to $3.50, maintains Buy - Investing.com
Analysts Set Geron Co. (NASDAQ:GERN) Price Target at $7.25 - MarketBeat
Geron (NASDAQ:GERN) Shares Down 4.6%Here's Why - MarketBeat
Geron (NASDAQ:GERN) Trading Down 4.6%Here's Why - MarketBeat
abrdn plc Raises Stake in Geron Co. (NASDAQ:GERN) - MarketBeat
Is Geron Corp. (GERN) the Best Nasdaq Stock Under $5 to Buy? - Insider Monkey
Interesting GERN Put And Call Options For March 21st - Nasdaq
Chicago Partners Investment Group LLC Sells 7,756 Shares of Geron Co. (NASDAQ:GERN) - ETF Daily News
Geron Corporation: Lackluster Share Price Performance Despite Reasonable Drug Launch - Seeking Alpha
Q4 Earnings Preview: Geron Sets Critical Financial Results DateKey Details Inside - StockTitan
Nvest Financial LLC Purchases Shares of 195,741 Geron Co. (NASDAQ:GERN) - MarketBeat
Geron Corp. (NASDAQ: GERN) Faces Decline: What’s Behind the 3.92% Drop? – Market - HPBL
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Geron Corp-Aktie (GERN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer |
Jul 08 '24 |
Sale |
4.56 |
674,348 |
3,073,004 |
0 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Option Exercise |
1.19 |
287,900 |
341,693 |
155,400 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Sale |
4.63 |
287,900 |
1,334,129 |
0 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Option Exercise |
1.06 |
421,875 |
447,188 |
421,875 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Sale |
4.64 |
421,875 |
1,959,609 |
0 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Option Exercise |
2.54 |
600,000 |
1,524,000 |
600,000 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Sale |
4.00 |
600,000 |
2,400,000 |
600,000 |
| LAWLIS V BRYAN | Director |
May 15 '24 |
Option Exercise |
1.94 |
35,000 |
67,900 |
35,000 |
| LAWLIS V BRYAN | Director |
May 15 '24 |
Sale |
3.75 |
35,000 |
131,250 |
0 |
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):